Fenofibrate, the generic name of Lipinz, and Rosuvastatin should not be used together, as both drugs can cause myalgia, rhabdomyolysis adverse reactions, therefore, when used together, it can increase the probability of rhabdomyolysis in patients. Fenofibrate, which has a more pronounced effect on the removal of serum triglycerides, can lead to myalgia, rhabdomyolysis and other adverse effects; Rosuvastatin, which mainly reduces serum cholesterol levels, can also lead to myalgia, myopathy, as well as the adverse effects of rhabdomyolysis, which is particularly more pronounced in patients who are using a dosage of more than 20mg of the drug, and therefore should not be used together. In the case of hyperlipidemia, the choice of medication can be based on each of the specific lipid markers, with fenofibrate preferred in hypertriglyceridemic patients and Rosuvastatin in hypercholesterolemic patients. If you need to use Fenofibrate or Rosuvastatin, please follow the doctor’s instructions for medication.